Literature DB >> 3041510

Pure mesenchymal neoplasms of the uterine corpus: selected problems.

R L Kempson1, M R Hendrickson.   

Abstract

The first part of this review includes a discussion of some issues in decision analysis as it applies to uterine mesenchymal tumors, as well as a discussion of some of the morphologic features and histochemical techniques that may be used to determine whether a mesenchymal tumor is demonstrating smooth muscle or endometrial stromal differentiation. Also included in the first part are caveats that the pathologist should observe before interpreting mesenchymal tumors of the uterus. The second part of the paper is devoted to morphologic diagnostic criteria and differential diagnosis.

Entities:  

Mesh:

Year:  1988        PMID: 3041510

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  5 in total

Review 1.  Recent advances in the histological and molecular classification of endometrial stromal neoplasms.

Authors:  Joana Ferreira; Ana Félix; Jochen K Lennerz; Esther Oliva
Journal:  Virchows Arch       Date:  2018-10-15       Impact factor: 4.064

2.  Leiomyomatosis with vascular invasion. A unified pathogenesis regarding leiomyoma with vascular microinvasion, benign metastasizing leiomyoma and intravenous leiomyomatosis.

Authors:  V Canzonieri; E S D'Amore; G Bartoloni; M Piazza; S Blandamura; A Carbone
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

3.  Rodent model of reproductive tract leiomyomata. Clinical and pathological features.

Authors:  J I Everitt; D C Wolf; S R Howe; T L Goldsworthy; C Walker
Journal:  Am J Pathol       Date:  1995-06       Impact factor: 4.307

4.  Bcl-2 expression and other clinicopathologic parameters in uterine leiomyosarcoma.

Authors:  Klaus Bodner; Barbara Bodner-Adler; Oliver Kimberger; Klaus Czerwenka; Klaus Mayerhofer
Journal:  Wien Klin Wochenschr       Date:  2004-02-28       Impact factor: 1.704

5.  Long Term Prognostic Implications of Expression of Glucose Transporter-1 and Hexokinase II in Patients with Stage I Uterine Leiomyosarcoma.

Authors:  Hitomi Tsukada; Toshinari Muramatsu; Masaki Miyazawa; Tetsuji Iida; Masae Ikeda; Masako Shida; Takeshi Hirasawa; Hiroshi Kajiwara; Masaru Murakami; Masanori Yasuda; Mikio Mikami
Journal:  Acta Histochem Cytochem       Date:  2012-04-21       Impact factor: 1.938

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.